Cargando…
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis
Disease modifying antirheumatic drugs (DMARDs) have improved the prognosis of autoimmune inflammatory arthritides but a large fraction of patients display partial or nonresponsiveness to front‐line DMARDs. Here, an immunoregulatory approach based on sustained joint‐localized release of all‐trans ret...
Autores principales: | McBride, David A., Kerr, Matthew D., Johnson, Wade T., Nguyen, Anders, Zoccheddu, Martina, Yao, Mina, Prideaux, Edward B., Dorn, Nicholas C., Wang, Wei, Svensson, Mattias N.D., Bottini, Nunzio, Shah, Nisarg J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104670/ https://www.ncbi.nlm.nih.gov/pubmed/36890657 http://dx.doi.org/10.1002/advs.202202720 |
Ejemplares similares
-
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis (Adv. Sci. 11/2023)
por: McBride, David A., et al.
Publicado: (2023) -
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
por: Hsieh, Wan-Chen, et al.
Publicado: (2020) -
Lipid‐based regulators of immunity
por: Johnson, Wade T., et al.
Publicado: (2021) -
Biodegradable scaffolds for enhancing vaccine delivery
por: Kerr, Matthew D., et al.
Publicado: (2023) -
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
por: Stanford, Stephanie M., et al.
Publicado: (2023)